CariƱo, Neriza B.
HRN: 21-19-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
MUPIROCIN 2%, 15G (TUBE)
05/24/2022
05/30/2022
TOPICAL
15gm
OD
S/P Repeat LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes